Quebec based Medicago to start late-phase clinical trial on COVID-19 vaccine
Metro MontrealMetro / Metro Montreal il y a 3 ans 86 Views 0
Quebec Metropolis-based pharmaceutical developer Medicago has announced it’s prepared to move forward with a part three medical trial of its COVID-19 vaccine candidate, after seeing “constructive” interim results from part two, the company stated on Tuesday.
Comments